Strand Therapeutics
110 employees
Engineered Biology
Series B · $256.0M
Open positions (3)
Company details
Team Size110
IndustryEngineered Biology
Funding
Total raised
$256.0M
Last stage
Series B
Investors
FPV Ventures
Total raised
$256.0M
Last stage
Series B
Investors
Darrell Irvine
Co-founder of Strand Therapeutics and founder of two other companies, Ankyra and Elicio. Serves on the Scientific Advisory Board.
Jake Becraft
Synthetic biologist and entrepreneur. PhD in Biological Engineering and Synthetic Biology from MIT. Led development of the world's first synthetic biology programming language for mRNA at MIT's Synthetic Biology Center.
LinkedInTasuku Kitada
Co-founded Strand and serves on its Board of Directors. PhD in Molecular Biology from UCLA. Prior to Strand, was Senior Biotechnology Analyst at Candriam Investors Group.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.